Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Nordic Nanovector ASA
Headquarters: Oslo, Norway
Website: N/A
Year Founded: 2009
Status: Merged
BioCentury | Mar 13, 2024
Management Tracks
IDRx names Clackson, Dahms to C-suite and Auspitz chair
Plus: new COO for radiopharma
BioCentury | Dec 1, 2023
Product Development
Radiopharmaceuticals’ multi-dimensional next wave
Target, ligand and radioisotope choices fuel the growing field
BioCentury | Aug 29, 2023
Management Tracks
Crossover-backed Arbor names Tamboli CFO
Plus: Atkinson named chief technical operations officer at Vertex, and updates from Confo, Flagship, Citryll and more
BioCentury | Jun 29, 2023
Management Tracks
Dallas replaces Cunningham as CEO of Rivus
Plus: Stephen Uden named CEO at Rallybio, and updates from Alloy, TScan and more
BioCentury | May 17, 2023
Management Tracks
FDA veteran Dunn to join Prothena’s board
Plus: Lucera named CFO at Editas, and updates from Erasca, Sangamo, AlloVir and more
BioCentury | Apr 19, 2023
Management Tracks
Astria promotes Matthews to CBO
Plus Engimmune hires Nieba as CEO and an update from Cardurion
BioCentury | Feb 3, 2023
Management Tracks
Graham named CEO of Roche Pharmaceuticals
Plus: Goswami becomes CFO at Illumina, and updates from SOBI, BDGene, Nordic and more
BioCentury | Dec 2, 2022
Regulation
Dec. 1 Quick Takes: FDA approves Rigel, Forma therapy for AML
Plus: Pfizer, Roivant form new unit around ulcerative colitis target, China’s Trinomab raises over $100M and updates from Nordic-APIM, Nectin, NIST and more
BioCentury | Nov 11, 2022
Regulation
Nov. 10 Quick Takes: BrainStorm falls on refusal-to-file letter from FDA
Plus: AZ dropping U.S. plans for Vaxzevria and updates from Neuraxpharm, Minoryx and more
BioCentury | Aug 26, 2022
Management Tracks
Leading China biotechs Everest, CStone announce CEO departures
Plus updates from BD, Sema4,
Items per page:
1 - 10 of 48